Screener
CorMedix CRMD EBITDA
Discontinued — last reported Q1 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from CorMedix’s reported figures.
The source filing: CorMedix’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 8:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001410098-26-000021
FAQ
- What is CorMedix's EBITDA?
- CorMedix (CRMD) reported EBITDA of $74.2M in Q1 2026.
- How has CorMedix's EBITDA changed year-over-year?
- CorMedix's EBITDA increased by 265.8% year-over-year, from $20.29M to $74.2M.
- What is the long-term trend for CorMedix's EBITDA?
- Over 3 years (2021 to 2025), CorMedix's EBITDA has grown at a 77.6% compound annual growth rate (CAGR), from -$29.38M to $164.66M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about CorMedix's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude